Lecture image placeholder

Premium content

Access to this content requires a subscription. You must be a premium user to view this content.

Monthly subscription - $9.99Pay per view - $4.99Access through your institutionLogin with Underline account
Need help?
Contact us
Lecture placeholder background
VIDEO DOI: https://doi.org/10.48448/v3g6-z905

technical paper

ENDO 2021

March 21, 2021

Live on Underline

Effects of Setmelanotide in Patients with POMC, PCSK1, or LEPR Heterozygous Deficiency Obesity in a Phase 2 Study

Please log in to leave a comment

Downloads

Transcript English (automatic)

Next from ENDO 2021

Primary Results From MATCH: Is Metomidate PET-CT superior to Adrenal venous sampling in predicting ouTCome from adrenalectomy in patients with primary Hyperaldosteronism
technical paper

Primary Results From MATCH: Is Metomidate PET-CT superior to Adrenal venous sampling in predicting ouTCome from adrenalectomy in patients with primary Hyperaldosteronism

ENDO 2021

21 March 2021

Similar lecture

What are the Unique aGHD Management Challenges as Pediatric Patients with GHD Transition to Adulthood?
symposium

What are the Unique aGHD Management Challenges as Pediatric Patients with GHD Transition to Adulthood?

ENDO 2020

David R Clemmons
David R Clemmons

10 June 2020

Stay up to date with the latest Underline news!

Select topic of interest (you can select more than one)

PRESENTATIONS

  • All Lectures
  • For Librarians
  • Resource Center
  • Free Trial
Underline Science, Inc.
1216 Broadway, 2nd Floor, New York, NY 10001, USA

© 2023 Underline - All rights reserved